Replies to post #172545 on OWC Pharmaceutical Research Corp (OWCP)

[mad dog2]

where do you vote my accounts have not sent me anything vanguard and td

[money2013]

Exactly!!!

[H_dog_taco]

I have a different take on it MjMilo. I think they wanted to keep the price down and scare as much retail as possible out.

The share structure really isnt bad enough to warrant a 1 for 700.

For me, patent allowance and MJ export from israel is all I need to know.

[PhenixBleu]

I will continue to build my position regardless of tomorrow's vote.

My version of accountability happens through their public communications: SEC Filings, company press releases, and Shareholder Letters. I see 45 in 2019.

Remember this quote?

"We will not provide responses to individual approaches between our public communications." This is from Hirsch's first Shareholder Letter.

Chairman Hirsch, Letter to Shareholders, September 14, 2017

There will be more business partners. They can license their technology. They can be acquired.

Dr. Hirsch has extensive executive and board level experience for more than the past 25 years in private and publicly listed companies in biopharmaceutical and agricultural biotech industries, among others, including direct experience in raising capital and leading M&A activity together with multi-cultural management skills, having managed companies in Israel, Brazil, UK, China and the United States.

From May 2016 to the present, Dr. Hirsch has served as Chairman of the Board of Directors of Foamix Pharmaceuticals Ltd (NASDAQ: FOMX), an Israeli-based clinical-stage specialty pharmaceutical company in late-stage clinical development and commercializing two proprietary products for the treatment of acne, rosacea and other skin conditions. Foamix collaborates with leading global pharmaceutical companies in the creation and commercialization of its advanced skin treatment products.

From August 2007 to the present, Dr. Hirsch has served as Group CEO of FuturaGene Limited and its predecessor company, FuturaGene Plc, which was listed on the AIM-London Stock Exchange, prior to acquisition by Suzano Pulp and Paper of Brazil (SUZB, BOVESPA, Sao Paulo) in July 2010. FuturaGene Limited is a world leader in the development of environmentally friendly solutions that improve and protect crop yields, engaged in the development and delivery of sustainable genetic solutions for global forestry, biopower, biofuels, and agricultural markets.

Dr. Hirsch’s educational experience includes a D.Phil in Cell Biology and Immunology from Oxford University, UK, in 1982, a B.Sc. degree with honors in Medical Biochemistry from the University of Capetown, South Africa in 1979, among other academic honors and awards from Oxford University and University of Capetown .

You better hope there's enough votes to defeat the r/s...

Personally I think the r/s is in the bag otherwise why try again with an even bigger ratio and zero accountability towards shareholders...

They still want a blank cheque.

If the r/s passes... shareholder's equity will have been totally destroyed...no way around it...

Unless you choose to trust the "company"...lol